Article
Apolipoprotein E-ε2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study.
Circulation research - 16 Feb 2024
Toribio-Fernández Raquel, Tristão-Pereira Catarina, Carlos Silla-Castro Juan, Callejas Sergio, Oliva Belen, Fernandez-Nueda Irene, Garcia-Lunar Ines, Perez-Herreras Cristina, María Ordovás José, Martin Pilar, Blanco-Kelly Fiona, Ayuso Carmen, Lara-Pezzi Enrique, Fernandez-Ortiz Antonio, Garcia-Alvarez Ana, Dopazo Ana, Sanchez-Cabo Fatima, Ibanez Borja, Cortes-Canteli Marta, Fuster Valentin
Abstract excerpt
BACKGROUND: APOE is a known genetic contributor to cardiovascular disease, but the differential role APOE alleles play in subclinical atherosclerosis remains unclear. METHODS: The PESA (Progression of Early Subclinical Atherosclerosis) is an observational cohort study that recruited 4184 middle-aged asymptomatic individuals to be screened for cardiovascular risk and multiterritorial subclinical atherosclerosis....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
